H.C. Wainwright Reiterates Buy Rating on Actuate Therapeutics (ACTU)

Go back to H.C. Wainwright Reiterates Buy Rating on Actuate Therapeutics (ACTU)
ACTUATE (NASDAQ: ACTU) Delayed: 1.82 -0.06 (3.19%)
Previous Close $1.88    52 Week High $6.07 
Open $1.89    52 Week Low $3.89 
Day High $1.90    P/E 12.13 
Day Low $1.82    EPS $0.15 
Volume 82,421